An International, Multicenter Evaluation of Comprehensive Medication Management by Pharmacists in ICU Recovery Centers
BACKGROUND: Post-intensive care syndrome (PICS) is defined as a new or worsening impairment in physical, cognitive, or mental health following critical illness. Intensive care unit recovery centers (ICU-RC) are one means to treat patients who have PICS. The purpose of this study is to describe the role of pharmacists in ICU-RCs.
RESEARCH QUESTION: What is the number and type of medication interventions made by a pharmacist at an ICU-RC at 12 different centers?.
STUDY DESIGN AND METHODS: This prospective, observational study was conducted in 12 intensive care units (ICUs)/ICU-RCs between September 2019 and July 2021. A full medication review was conducted by a pharmacist on patients seen at the ICU-RC.
RESULTS: 507 patients were referred to the ICU-RC. Of these patients, 474 attended the ICU-RC and 472 had a full medication review performed by a pharmacist. Baseline demographic and hospital course data were obtained from the electronic health record and at the ICU-RC appointment. Pharmacy interventions were made in 397 (84%) patients. The median number of pharmacy interventions per patient was 2 (interquartile range [IQR] = 1,3). Medications were stopped and started in 124 (26%) and 91 (19%) patients, respectively. The number of patients that had a dose decreased and a dose increased was 51 (11%) and 43 (9%), respectively. There was no difference in the median total number of medications that the patient was prescribed at the start and end of the patient visit (10, IQR = 5, 15). Adverse drug event (ADE) preventive measures were implemented in 115 (24%) patients. ADE events were identified in 69 (15%) patients. Medication interactions were identified in 30 (6%) patients.
INTERPRETATION: A pharmacist plays an integral role in an ICU-RC resulting in the identification, prevention, and treatment of medication-related problems. This paper should serve as a call to action on the importance of the inclusion of a pharmacist in ICU-RC clinics.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:38 |
|---|---|
| Enthalten in: |
Journal of intensive care medicine - 38(2023), 10 vom: 31. Okt., Seite 957-965 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Stollings, Joanna L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adverse drug event |
|---|
| Anmerkungen: |
Date Completed 26.09.2023 Date Revised 26.09.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1177/08850666231176194 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357014995 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357014995 | ||
| 003 | DE-627 | ||
| 005 | 20231226071656.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1177/08850666231176194 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1189.xml |
| 035 | |a (DE-627)NLM357014995 | ||
| 035 | |a (NLM)37198935 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Stollings, Joanna L |e verfasserin |4 aut | |
| 245 | 1 | 3 | |a An International, Multicenter Evaluation of Comprehensive Medication Management by Pharmacists in ICU Recovery Centers |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.09.2023 | ||
| 500 | |a Date Revised 26.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Post-intensive care syndrome (PICS) is defined as a new or worsening impairment in physical, cognitive, or mental health following critical illness. Intensive care unit recovery centers (ICU-RC) are one means to treat patients who have PICS. The purpose of this study is to describe the role of pharmacists in ICU-RCs | ||
| 520 | |a RESEARCH QUESTION: What is the number and type of medication interventions made by a pharmacist at an ICU-RC at 12 different centers? | ||
| 520 | |a STUDY DESIGN AND METHODS: This prospective, observational study was conducted in 12 intensive care units (ICUs)/ICU-RCs between September 2019 and July 2021. A full medication review was conducted by a pharmacist on patients seen at the ICU-RC | ||
| 520 | |a RESULTS: 507 patients were referred to the ICU-RC. Of these patients, 474 attended the ICU-RC and 472 had a full medication review performed by a pharmacist. Baseline demographic and hospital course data were obtained from the electronic health record and at the ICU-RC appointment. Pharmacy interventions were made in 397 (84%) patients. The median number of pharmacy interventions per patient was 2 (interquartile range [IQR] = 1,3). Medications were stopped and started in 124 (26%) and 91 (19%) patients, respectively. The number of patients that had a dose decreased and a dose increased was 51 (11%) and 43 (9%), respectively. There was no difference in the median total number of medications that the patient was prescribed at the start and end of the patient visit (10, IQR = 5, 15). Adverse drug event (ADE) preventive measures were implemented in 115 (24%) patients. ADE events were identified in 69 (15%) patients. Medication interactions were identified in 30 (6%) patients | ||
| 520 | |a INTERPRETATION: A pharmacist plays an integral role in an ICU-RC resulting in the identification, prevention, and treatment of medication-related problems. This paper should serve as a call to action on the importance of the inclusion of a pharmacist in ICU-RC clinics | ||
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a adverse drug event | |
| 650 | 4 | |a medication reconciliation | |
| 650 | 4 | |a pharmacist | |
| 650 | 4 | |a post-intensive care syndrome | |
| 650 | 4 | |a post-intensive care syndrome clinic | |
| 700 | 1 | |a Poyant, Janelle O |e verfasserin |4 aut | |
| 700 | 1 | |a Groth, Christine M |e verfasserin |4 aut | |
| 700 | 1 | |a Rappaport, Stephen H |e verfasserin |4 aut | |
| 700 | 1 | |a Kruer, Rachel M |e verfasserin |4 aut | |
| 700 | 1 | |a Miller, Emily |e verfasserin |4 aut | |
| 700 | 1 | |a Whitten, Jessica A |e verfasserin |4 aut | |
| 700 | 1 | |a Mcintire, Allyson M |e verfasserin |4 aut | |
| 700 | 1 | |a McDaniel, Cara M |e verfasserin |4 aut | |
| 700 | 1 | |a Betthauser, Kevin D |e verfasserin |4 aut | |
| 700 | 1 | |a Mohammad, Rima A |e verfasserin |4 aut | |
| 700 | 1 | |a Kenes, Michael T |e verfasserin |4 aut | |
| 700 | 1 | |a Korona, Rebecca Bookstavar |e verfasserin |4 aut | |
| 700 | 1 | |a Barber, Alexandra E |e verfasserin |4 aut | |
| 700 | 1 | |a MacTavish, Pamela |e verfasserin |4 aut | |
| 700 | 1 | |a Dixit, Deepali |e verfasserin |4 aut | |
| 700 | 1 | |a Yeung, Siu Yan A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of intensive care medicine |d 1991 |g 38(2023), 10 vom: 31. Okt., Seite 957-965 |w (DE-627)NLM08584439X |x 1525-1489 |7 nnns |
| 773 | 1 | 8 | |g volume:38 |g year:2023 |g number:10 |g day:31 |g month:10 |g pages:957-965 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1177/08850666231176194 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 38 |j 2023 |e 10 |b 31 |c 10 |h 957-965 | ||